Ervebo ebola zaire vaccine, live suspension for intramuscular injection. The recommended tukysa dose reductions and dosage modifications for adverse reactions are provided in. Everyone living with a cancer diagnosis could use some support along the way. Vemurafenib definition of vemurafenib by medical dictionary. The log of the distribution coefficient octanolwater at ph 7 is 5. Gently transfer the vemurafenib from its package to a small medicine or other. Vemurafenib is used to treat melanoma skin cancer that. Vumerity diroximel fumarate delayedrelease capsules, for oral use. Vemurafenib is also being studied in the treatment of other types of cancer. Sections or subsections omitted from the full prescribing information are not listed. Zelboraf vemurafenib dosing, indications, interactions. Vemurafenib side effects, dosage, interactions drugs.
Zelboraf is not indicated for treatment of patients with wildtype braf melanoma. The following packaging configurations are available. Vemurafenib is approved to treat patients whose disease has a certain mutation in the braf gene, including. Vemurafenib does not have antitumour effects against melanoma cell lines with the wildtype braf mutation. Your healthcare provider will do blood tests to check your liver function before you start taking stivarga and during your treatment with stivarga to check for liver problems. Cotellic is a prescription medicine that is used with the medicine. Here you will find information and tools you need to stay informed and connected, including. Stivarga regorafenib can cause liver problems, which can be serious and sometimes lead to death.
Zelboraf vemurafenib is supplied as 240 mg filmcoated tablets with vem debossed on one side. The related drug information index provides comprehensive access to all drug information related to a specific drug types of content include full prescribing information, drug summaries, full prescribing information continuing medication education full pi cme, medication guides, risk evaluation and mitigation strategies rems summaries, rems continuing medication education rems cme, and. Melanoma that cannot be removed by surgery or has metastasized spread to other parts of the body. Get emergency medical help if you have signs of an allergic reaction hives, difficult breathing, swelling in your face or throat or a severe skin reaction fever, sore throat, burning in your eyes, skin pain, red or purple skin rash that spreads and causes blistering and peeling seek medical treatment if you have a serious drug reaction that can affect many parts. Vemurafenib is a kinase inhibitor available as 240 mg tablets for. The solubility of sunitinib malate in aqueous media over the range ph 1. Highlights of prescribing information advanced renal.
Zelboraf tablets price in india, vemurafenib by genentech. As for all medicines, data on the use of zelboraf are continuously monitored. Vemurafenib has favorable pharmacokinetics as compared to the other structurally similar braf v600 mutated kinases. Braftovi encorafenib capsules, for oral use initial u. Cotellic is not indicated for treatment of patients with wildtype braf melanoma. Interrupt and then reduce or discontinue stivarga for hepatotoxicity as manifested by elevated liver. Vemurafenib is metabolized by cyp3a4 and the metabolites make up 5% of the components in plasma. Refer to the dabrafenib prescribing information for recommended dabrafenib dosing information. Vemurafenib is an orally bioavailable, atpcompetitive, smallmolecule inhibitor of brafv600e kinase with potential antineoplastic activity. It inhibits braf v600e and also has inhibitory activity in vitro against several other kinds of kinases, including craf, araf and wildtype braf. It is used to treat melanoma, a type of skin cancer, and. If a family member, friend, or caregiver needs to give vemurafenib to you, they also need to follow these steps. Get emergency help right away if you get symptoms such as chest pain, shortness of breath, racing heartbeat, swelling in lower legs, feet and abdomen, feel lightheaded or faint, tiredness, nausea, vomiting, or sweat a lot. Side effects reported with zelboraf are carefully evaluated and any necessary action taken to protect patients.
D indications genetic implication treatment of unresectable or metastatic melanoma with braf v600emutation. Cotellic is a kinase inhibitor indicated for the treatment of patients with unresectable or metastatic melanoma with a braf v600e or v600k mutation, in combination with vemurafenib. Highlights of prescribing information these highlights. Zelboraf vemurafenib is a braf inhibitor that blocks the function of the v600emutated braf protein which can stop the melanoma cells from growing and dividing. It has the molecular formula c 23 h 18 clf 2 n 3 o 3 s and a molecular weight of 489. Zelboraf vemurafenib is a type of cancer treatment called a cancer growth blocker. Vemurafenib can slow down the removal of other medications from your body, which may affect how they work. Zelboraf vemurafenib is a kinase inhibitor available as 240 mg tablets for oral use. Exposure to ultraviolet radiation and sun sensitivity are additional risk factors for the disease. Examples of affected drugs include caffeine, warfarin, among others. This product information was approved at the time this auspar was published. Vemurafenib tab zelboraf by genentech is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Vemurafenib is active against several human tumor serinethreonine protein kinase braf melanoma xenograft models.
Zelboraf fda prescribing information, side effects and uses. Zelboraf vemurafenib tablets are indicated for the treatment of patients with unresectable or metastatic melanoma with braf v600e mutation as detected by an fdaapproved test. Dermatologic toxicities occurred in 90% of patients and were severe ncictc grade 3 and higher in 15% of patients receiving vectibix monotherapy see dosage and administration 2. Nilotinib drug substance, in the form of monohydrochloride monohydrate, is a white to slightly yellowish to slightly greenish yellow powder with the molecular formula and weight, respectively, of c 28 h 22 f 3 n 7 ohcl h 2 o and 584 corresponding molecular formula and weight of nilotinib base, anhydrous are c 28 h 22 f 3 n 7 o and 529. The newly approved drug zelboraf appears to nearly double the length of time a person can expect to live with advanced melanoma skin cancer, a new study shows. Pharmaceuticals and medical devices agency of japan. Official site for healthcare professionals nexavar. It is used to treat metastatic melanoma skin cancer.
Vemurafenib is a cyp3a4 substrate and cyp1a2 inhibitor avoid coadministration of vemurafenib with strong cyp3a4 inhibitors eg, ketoconazole, itraconazole, clarithromycin, saquinavir, ritonavir, indinavir, nelfinavir, voriconazole and replace and use alternative drugs when possible. In the event of toxicity, doses may be delayed, but all treatment must be administered within 16 weeks of the first dose see clinical studies 14. Skyrizi risankizumabrzaa full prescribing information. Zelboraf vemurafenib cost, side effects, dosage for. Vemurafenib blocks these downstream processes to inhibit tumour growth and eventually trigger apoptosis. Vemurafenib is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. Hepatotoxicity severe and sometimes fatal hepatotoxicity has occurred in clinical trials see warnings and precautions 5. The recommended dose of yervoy ipilimumab is 3 mgkg administered intravenously iv over 90 minutes every 3 weeks for a maximum of 4 doses. Dose increase or reduction is recommended based on individual safety and tolerability. Determine if patients are taking drugs that could slow heart rate or atrioventricular conduction see warnings and. The risk factors most associated with malignant melanoma include a family history of melanoma, atypical moles, and previous melanoma. Vemurafenib is a highly efficient braf inhibitor for metastatic melanoma patients carrying the v600 mutation. A specific test, approved by fda, known as the braf v600e or braf v600k mutation, is recommended before starting cobimetinib therapy to determine the chance that the medication will kill melanoma cells.
See full prescribing information for complete boxed. Tell your healthcare provider right away if you experience yellowing of. Melanoma is a lifethreatening form of skin cancer that occurs due to genetic and environmental factors. Vemurafenib is a competitive smallmolecule serinethreonine kinase inhibitor that functions by binding to the atpbinding domain of mutant braf. Highlights of prescribing information these highlights do. Vemurafenib has the chemical name propane1sulfonic acid 354chlorophenyl1hpyrrolo2,3bpyridine3carbonyl 2,4difluorophenylamide. Sunitinib malate is a yellow to orange powder with a pka of 8. It belongs to a group of cancer fighting medications called antineoplastics, and more specifically to a group of medications called monoclonal antibodies. If your healthcare provider prescribes zelboraf vemurafenib, also read the medication guide that comes with zelboraf. See 17 for patient counseling information and medication.
Gloves are not necessary if you give the drug to yourself. Zelboraf is a kinase inhibitor indicated for the treatment of patients with unresectable or metastatic melanoma with braf v600e mutation as detected by an fdaapproved test. Zelboraf may double survival for some melanoma patients. Vemurafenib is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Information below provided by the pharmaceutical company. Package inserts revised for vemurafenib, hydroxyzine in. Easy to read fda package insert, drug facts, dosage and administration, and adverse effects for decadron dexamethasone. Highlights of prescribing information tafinlar with. Monitor hepatic function prior to and during treatment see warnings and precautions 5.
Over the course of treatment, patients who tolerate inlyta for at least two consecutive weeks with no adverse reactions grade 2 according to the common toxicity criteria for adverse events ctcae, are normotensive, and are not receiving antihypertension medication, may. Highlights of prescribing information perforation can. Vemurafenib selectively binds to the atpbinding site of brafv600e kinase and inhibits its activity, which may result in an inhibition of an overactivated mapk signaling pathway downstream in brafv600e kinaseexpressing tumor cells and a reduction. Summary of investigation results hydroxyzine hydrochloride, hydroxyzine pamoate. Zelboraf is not indicated for use in patients with wildtype braf melanoma. Action inhibits mutated forms of the enzyme kinase.
198 1484 1654 484 382 1436 1200 452 622 904 461 1684 493 1044 946 633 1140 98 583 384 167 1176 1285 1039 1251 120 938 972 1181 1425 691 1474 1379 952 1021